
Please try another search
Breaking News
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1079 | 1032 | 1072 | 1174 | 1445 | 2391 |
Fund Return | 7.87% | 3.19% | 7.19% | 5.51% | 7.65% | 9.11% |
Place in category | 266 | 517 | 504 | 293 | 161 | 92 |
% in Category | 26 | 50 | 52 | 42 | 29 | 28 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global Technology Fund W Acc GBP | 1.3B | 4.55 | 16.08 | 22.31 | ||
Global Technology Fund A DIST GBP | 34.53M | 18.73 | 11.59 | 20.94 | ||
Global Multi Asset Income Fund I Ag | 16.46M | 2.18 | 2.23 | 5.29 | ||
EM Fund W Acc GBP | 19.76M | 2.15 | -4.57 | 4.92 | ||
European Dynamic Growth Fund W Acc | 17.14M | 8.00 | 4.22 | 9.93 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund U G | 3.51B | 5.15 | 9.71 | 9.90 | ||
Wellington Global Health Care EquiG | 1.71B | 6.70 | 4.03 | 11.14 | ||
Adamant Medtech I GBP | 1.44B | 7.47 | 6.21 | 12.34 | ||
Pharmaceuticals Index Trust I Acc | 462.89M | 3.24 | 1.99 | 9.39 | ||
Pharmaceuticals Index Trust I Dist | 46M | 3.19 | 1.99 | 9.38 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Boston Scientific | US1011371077 | 8.06 | 89.70 | -8.93% | |
UnitedHealth | US91324P1021 | 8.03 | 525.05 | -2.85% | |
Eli Lilly | US5324571083 | 5.67 | 738.21 | -6.45% | |
Stryker | US8636671013 | 5.50 | 345.80 | -6.07% | |
Novo Nordisk B | DK0062498333 | 5.20 | 428.5 | -0.81% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Sell |
Technical Indicators | Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review